Independent DirectorDr. Srinivas Akkaraju M.D. Ph.D. is an Independent Director of ZS Pharma Inc. Dr. Akkaraju has over 16 years of investment and operational experience in the life sciences sector. Dr. Akkaraju has served as a General Partner concentrating on biopharmaceutical investments of Sofinnova Ventures since April 2013. Prior to Sofinnova Ventures Dr. Akkaraju served as a Managing Director at New Leaf Venture Partners from January 2009 to April 2013. Prior to New Leaf Venture Partners Dr. Akkaraju was a founding Managing Director at Panorama Capital the venture spinout from the arm of J.P. Morgan Partners that specialized in biotech and information technology investments. Before forming Panorama Capital he was a part of the biotech investment team of J.P. Morgan Partners from April 2001 to July 2006 most recently serving as Partner. Prior to J.P. Morgan Partners Dr. Akkaraju held business and corporate development positions at Genentech Inc. from October 1998 to March 2001. Dr. Akkarajus past board memberships have included Piramed Ltd. Eyetech Pharmaceuticals Inc. and Synageva BioPharma Corporationration He currently serves on the boards of Seattle Genetics Inc. Intercept Pharmaceuticals Inc. and Versartis Inc
Age: 46 Director Since 2014 Ph.DAkkaraju received his B.A. degrees in both Biochemistry and Computer Science from Rice University and M.D. and Ph.D. degrees in Immunology from Stanford University School of Medicine.